MDA-MB-231 CAGA12-Luc/TK Renilla cell line

The human breast cancer cell line MDA-MB-31 modified for use as a reporter cell line for Activin and TGF-beta signalling.

Contributors

Inventor Institute
Caroline Hill The Francis Crick Institute
SKU: 156437
Product description: The human breast cancer cell line MDA-MB-31 modified for use as a reporter cell line for Activin and TGF-beta signalling. The cell line stably expresses CAGA12-Luc, a Smad3/Smad4-dependent reporter containing 12 copies of the CAGAC sites (AGAC motif underlined) from the PAI-1 promoter. This is a Smad3/Smad4-dependent reporter, although it also binds complexes of Smad2 exon 3 with Smad4. The cell line also contains a Renilla reporter driven by the thymidine kinase (TK) promoter to act as an internal control.
Conditional description: In the presence of activin and TGF-beta signalling luciferase is expressed.
Production details: Made by transfecting the breast cancer cell line MDA-MB-231 with CAGA12-Luc with pRetroSuper for puromycin resistance and then TK Renilla with pCMV-Bsd for blasticidin resistance.Clonal
Parental cell line: MDA-MB-231 cell line
Disease: Cancer
Related tools: HEK293T CAGA12-Luc/TK Renilla cell line
Cat. #: 156437
Tool sub type: Continuous
Unit size: 1×10^6 cells / vial
Cancer types: Breast cancer
Research Fields: Cancer;Cell signaling and signal transduction;Developmental biology
Organism: Human
Tissue: Breast
Model: Reporter
Cancer Types In Detail: Breast cancer
Format: Frozen
Storage conditions: Liquid Nitrogen
Shipping conditions: Dry ice
Growth medium: Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal calf serum (FCS)+ 50 ?g/ml blasticidin
Recommended controls: MDA-MB-231 parental line
Mycoplasma free: Yes
Biosafety level: 1
References:

Grnroos et al. 2012. Mol Cell Biol. 32(14):2904-16. PMID: 22615489.

Related Tools for Cell lines

Cat. # Tool Name
156438 HEK293T CAGA12-Luc/TK Renilla cell line Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.